Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Oropharyngeal Carcinoma

Clinical trial condition

Recurrent Oropharyngeal Carcinoma

Explore clinical trials studying Recurrent Oropharyngeal Carcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Oropharyngeal Carcinoma trial results

Recruiting

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

NCT05799144

Conditions: Head and Neck Neoplasms, Metastatic Oropharyngeal Carcinoma, Neoplasms, +8 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Recruiting

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

NCT06997068

Conditions: Carcinoma, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Cancer, +34 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details